The Belgians are coming - Mayo Clinic-linked firm opening Roch. subsidary
Here's some from a piece I whipped up today about a Belgium biotech company, Cardio3, opening a U.S. office in the US. I've have been following these guys for years.
They are a pretty interesting firm.
The whole story is in today's print edition, including more about the potential of what this could mean for Rochester.
After years of talks, a Belgium company that uses stem cells to repair the heart is coming to Rochester in what local officials hope will be the start of a cluster of regenerative medicine firms here.
Cardio3 BioSciences, which is based on Mayo Clinic-licensed research by Dr. Atta Behfar and Dr. Andre Terzic, uses a patient's own stem cells from bone marrow to repair heart damage.
Clinical trials with patients in Europe have shown positive results. Now the company is establishing a subsidiary in Rochester to begin trials in the United States.
"What is unique about this is it's Mayo intellectual property that they are commercializing, which they took to it Belgium … and now it has come full circle back to Rochester," said Rochester Area Economic Development Inc. President Gary Smith. "That is a big thing … a very big thing."